GlaxoSmithKline's Hib vaccine obtains FDA approval

08/20/2009 | Philadelphia Inquirer, The

GlaxoSmithKline gained accelerated FDA clearance for Hiberix, a vaccine against Haemophilus influenzae Type B, which causes diseases such as meningitis and pneumonia. The approval allows the drug to be used as a booster in children 15 months to 4 years old and is part of an effort to address a shortage of Merck & Co.'s PedvaxHIB.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA